Uricosuric agent
This page covers all Uricosuric agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting URAT1 (urate transporter 1).
Targets
Marketed (1)
- Benzbromarone (drug) · Tottori University Hospital · Rheumatology
Benzbromarone inhibits renal urate reabsorption by blocking the urate transporter URAT1, thereby increasing urinary uric acid excretion and lowering serum uric acid levels.
Phase 3 pipeline (1)
- Probenecid 500 Milligrams (mg) · University of Miami · Rheumatology
Probenecid inhibits the renal tubular reabsorption of uric acid, increasing urinary excretion and lowering serum uric acid levels.